30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Alto Neuroscience Inc (ANRO)

Track

The most recent insider trading activity occurred on July 10, 2024. Chief Medical Officer Adam Savitz made multiple purchases totaling approximately $52,834. Prior to this, on March 28, 2024, Chief Financial Officer Nicholas Conrad bought shares worth about $100,628. Earlier in the year, on February 6, 2024, significant buying activity was observed from multiple executives and a large investor.
Stock chart
Ticker: ANRO Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Savitz Adam
CHIEF MEDICAL OFFICER
1 purchase — total 38,748 USD
Buy 10 Jul 2024
Value US$550,668.12 | Price 347.61 | Shares 33,919
Buy 9 Jul 2024
Value US$2,503,865.52 | Price 337.44 | Shares 28,862
Buy 9 Jul 2024
Value US$4,675,034.46 | Price 167.93 | Shares 92,563
Buy 28 Mar 2024
Value US$75,348.00 | Price 16.56 | Shares 4,550
Buy 28 Mar 2024
Value US$25,280.00 | Price 15.80 | Shares 1,600
Buy 6 Feb 2024
Value US$9,600,000.00 | Price 16.00 | Shares 600,000
Buy 6 Feb 2024
Value US$25,008.00 | Price 16.00 | Shares 1,563
Buy 6 Feb 2024
Value US$272,000.00 | Price 16.00 | Shares 17,000
Buy 6 Feb 2024
Value US$50,000.00 | Price 16.00 | Shares 3,125
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-11 2024-07-10 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
33,919 -0.6%
347.61
US$550,668 		33,919 -0.6% 347.61 US$550,668
2024-07-11 2024-07-09 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
28,862 +35.5%
337.44
US$2,503,866 		28,862 +35.5% 337.44 US$2,503,866
2024-07-11 2024-07-09 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
92,563 -30.1%
167.93
US$4,675,034 		92,563 -30.1% 167.93 US$4,675,034
2024-04-01 2024-03-28 B Purchase
1.3
Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER

Officer
4,550 +20.4%
16.56
US$75,348 		4,550 +20.4% 16.56 US$75,348
2024-04-01 2024-03-28 B Purchase
1.3
Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER

Officer
1,600 +7.7%
15.80
US$25,280 		1,600 +7.7% 15.80 US$25,280
2024-02-08 2024-02-06 B Purchase
Alpha Wave Global, LP
Large shareholder
600,000 +19.3%
16.00
US$9,600,000 		600,000 +19.3% 16.00 US$9,600,000
2024-02-07 2024-02-06 B Purchase
1.3
Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER

Officer
1,563 +inf%
16.00
US$25,008 		1,563 +inf% 16.00 US$25,008
2024-02-07 2024-02-06 B Purchase
0.9
Savitz Adam

CHIEF MEDICAL OFFICER

Officer
17,000 +216.5%
16.00
US$272,000 		17,000 +216.5% 16.00 US$272,000
2024-02-07 2024-02-06 B Purchase
Etkin Amit

PRESIDENT AND CEO

Executive Director
3,125 +0.3%
16.00
US$50,000 		3,125 +0.3% 16.00 US$50,000
Explore more

More insider trading research around Alto Neuroscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America